Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites. (2016)
Attributed to:
CHARACTERISING KYNURENINE 3-MONOOXYGENASE (KMO) AS A THERAPEUTIC TARGET FOR HUNTINGTON'S DISEASE
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1604453113
PubMed Identifier: 27114543
Publication URI: http://europepmc.org/abstract/MED/27114543
Type: Journal Article/Review
Volume: 113
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 19
ISSN: 0027-8424